Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001628280-26-015421 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 6, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
49,554
Total Value
$363,571.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 3, 2026 | Exercise/Conversion | 7,318 | $3.79 | $27,733.76 | 152,673 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 3, 2026 | Exercise/Conversion | 6,237 | $3.79 | $23,636.98 | 158,910 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 3, 2026 | Sale | 13,555 | $18.22 | $246,909.75 | 145,355 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Exercise/Conversion | 2,963 | $3.79 | $11,229.18 | 148,318 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 2,963 | $18.25 | $54,061.71 | 145,355 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Mar 3, 2026 | Exercise/Conversion | 7,318 | $0.00 | $0.00 | 58,144 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Mar 3, 2026 | Exercise/Conversion | 6,237 | $0.00 | $0.00 | 82,747 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Mar 4, 2026 | Exercise/Conversion | 2,963 | $0.00 | $0.00 | 79,784 | Direct | โ | View Details |